On June 5, 2020, The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), awarded $20.3 million to 44 recipients, increasing the number of fellows at accredited addiction medicine and addiction psychiatry fellowship programs. The awardees train addiction specialists at facilities in high-need communities that integrate behavioral and primary care services.
Post date: June 26, 2020
A recent commentary in the Annals of Internal Medicine addresses the negative physical and psychological effects of the COVID-19 pandemic on healthcare workers (HCWs). The authors share lessons learned from observations of HCWs during the SARS and H1N1 outbreaks and summarize possible best practices to help reduce adverse effects for HCWs and promote institutional resilience. These practices follow1:
Post date: June 26, 2020
The National Academies of Sciences, Engineering, and Medicine will host a two-part webinar series examining approaches to help ease delivery of key components of care for people with mental health and substance use disorders in primary care settings.
Post date: May 26, 2020
A recent blog post published by Health Affairs describes some of the barriers patients face trying to access opioid agonist therapy during the COVID-19 pandemic.
Post date: April 28, 2020
A recent article published in The Guardian describes some of the hardships rural hospitals in the United States are facing during the COVID-19 pandemic. While the pandemic has severely strained the capacities of some of the wealthiest healthcare systems in this country, small rural hospitals such as the one detailed in this article, have struggled just to keep their doors open for service. New shelter-in-place orders and social distancing guidelines (e.g., prohibiting elective surgeries) have... Read more about "**Rural Hospitals Battling To Stay Alive During the COVID-19 Pandemic"
Post date: April 24, 2020
The White House Office of National Drug Control Policy (ONDCP) released the Administration’s National Drug Control Strategy 2020 (664KB), which “aims to reduce substance use through public health and public safety measures.” The 2020 National Drug Control Strategy focuses on reducing the number of Americans dying from drug overdoses.
Post date: March 02, 2020
The Board of Scientific Counselors of the National Center for Injury Prevention and Control (BSC/NCIPC) has established an Opioid Workgroup (OWG) to provide expert input and observations on a possible update or expansion of the... Read more about "CDC Seeks Members for new Opioid Workgroup"
Post date: January 17, 2020
In September of this year CDC will be hosting a symposium in Washington, DC focused on empirical evaluation of opioid-use related survey questions. In preparation for this meeting, they are seeking input from both federal and non-federal partners to better understand what measures are being used and how those measures have been evaluated for opioid-use related survey questions.  The intent is to hold a meeting to discuss findings and to put together a final compendium from the symposium to... Read more about "Opioid Survey Question Evaluation Symposium to be held in September 2020"
Post date: January 17, 2020
One of the issues that further contributes to making the opioid epidemic problematic is the lack of treatment options for individuals who live in rural areas. In 2016, AHRQ invested in a grant initiative, Increasing Access to Medication-Assisted Treatment of Opioid Abuse in Rural Primary Care Practices, in order to help rural primary care practices deliver medication-assisted... Read more about "Dissemination of Primary Care MAT Grantees Lessons Learned"
Post date: January 15, 2020